Helicobacter pylori
Medicine & Life Sciences
100%
Stomach Neoplasms
Medicine & Life Sciences
46%
Rifabutin
Medicine & Life Sciences
32%
Metronidazole
Medicine & Life Sciences
30%
Stomach
Medicine & Life Sciences
25%
sitafloxacin
Medicine & Life Sciences
25%
Drug Therapy
Medicine & Life Sciences
25%
MicroRNAs
Medicine & Life Sciences
24%
Matsuda, S. ,
Kawakubo, H. ,
Okamura, A. ,
Takahashi, K. ,
Toihata, T. ,
Takemura, R. ,
Mayanagi, S. ,
Hirata, K. ,
Irino, T. ,
Hamamoto, Y. ,
Takeuchi, H. ,
Facs ,
Watanabe, M. &
Kitagawa, Y. ,
2022 8月 1 ,
In: Annals of surgery. 276 ,
2 ,
p. 298-304 7 p. 研究成果: Article › 査読
Esophageal Squamous Cell Carcinoma
100%
Drug Therapy
49%
Recurrence
48%
Chemoradiotherapy
38%
Residual Neoplasm
38%
Inokuchi, K. ,
Mori, H. ,
Matsuzaki, J. ,
Hirata, K. ,
Harada, Y. ,
Saito, Y. ,
Suzuki, H. ,
Kanai, T. &
Masaoka, T. ,
2022 8月 ,
In: Helicobacter. 27 ,
4 , e12900.
研究成果: Article › 査読
Rifabutin
100%
Helicobacter pylori
65%
1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine
51%
Safety
39%
Amoxicillin
31%
Shimozaki, K. ,
Hirata, K. ,
Sato, T. ,
Nakamura, M. ,
Kato, K. ,
Hirano, H. ,
Kumekawa, Y. ,
Hino, K. ,
Kawakami, K. ,
Kito, Y. ,
Matsumoto, T. ,
Kawakami, T. ,
Komoda, M. ,
Nagashima, K. ,
Sato, Y. ,
Yamazaki, K. ,
Hironaka, S. ,
Takaishi, H. ,
Hamamoto, Y. &
Muro, K. ,
2022 12月 ,
In: Clinical Colorectal Cancer. 21 ,
4 ,
p. 339-346 8 p. 研究成果: Article › 査読
Vascular Endothelial Growth Factor A
100%
Colorectal Neoplasms
92%
Registries
91%
Safety
67%
Survival
27%
Shimozaki, K. ,
Sukawa, Y. ,
Sato, Y. ,
Horie, S. ,
Chida, A. ,
Tsugaru, K. ,
Togasaki, K. ,
Kawasaki, K. ,
Hirata, K. ,
Hayashi, H. ,
Hamamoto, Y. &
Kanai, T. ,
2021 7月 ,
In: Future Oncology. 17 ,
20 ,
p. 2593-2603 11 p. 研究成果: Article › 査読
Immediate Hypersensitivity
100%
Serum Albumin
77%
Stomach Neoplasms
65%
Renal Cell Carcinoma
36%
Non-Small Cell Lung Carcinoma
33%
Kawakami, H. ,
Hironaka, S. ,
Esaki, T. ,
Chayama, K. ,
Tsuda, M. ,
Sugimoto, N. ,
Kadowaki, S. ,
Makiyama, A. ,
Machida, N. ,
Hirano, H. ,
Hirata, K. ,
Hara, H. ,
Yabusaki, H. ,
Komatsu, Y. &
Muro, K. ,
2021 2月 2 ,
In: Cancers. 13 ,
4 ,
p. 1-12 12 p. , 805.
研究成果: Article › 査読
Ipilimumab
100%
Nivolumab
96%
Esophagogastric Junction
91%
Microsatellite Instability
87%
Microsatellite Repeats
75%